Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZMO -- Ignore unavailable to you. Want to Upgrade?

To: jeffbas who wrote (74)	9/13/1999 6:26:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 438

Jeff: Yes, Science would be just fine. Today's rally.... the daytraders are focused on Folkman, yes. And, yes, the breast Ca vaccine is interesting (and fresh in the news). However, today's big news was gene profiling.... AFFX..... so, I'm leaning toward believing that the underlying strength was neither the ENMD news or breast, but SAGE. The breast vaccine.... it NEEDS to be tried. I am of the opinion that the Rosenberg efforts with melanoma..... purified "self" antigens (tissue-specific), delivered via dendritic cells.... is a more probable route to success. However, the concept of trying to use dendritic cells to test if "tumor-specific" responses can be elicited is a must do. Rick